Asset Details
Do you wish to reserve the book?
Using Remimazolam to Generate Hemodynamically Stable Burst Suppression: A Case Report and Literature Review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Using Remimazolam to Generate Hemodynamically Stable Burst Suppression: A Case Report and Literature Review
Do you wish to request the book?
Using Remimazolam to Generate Hemodynamically Stable Burst Suppression: A Case Report and Literature Review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Using Remimazolam to Generate Hemodynamically Stable Burst Suppression: A Case Report and Literature Review
2025
Overview
Remimazolam is a short‐acting benzodiazepine that was approved by the United States Food and Drug Administration (FDA) in 2020 for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 min or less. Given its recent introduction, the use of remimazolam for general anesthesia and monitored anesthesia care (MAC) remains an area of ongoing investigation. In this report, we present the first documented case demonstrating that remimazolam can achieve hemodynamic stable burst suppression in a critically ill patient undergoing emergent craniectomy and aneurysm clipping. Additionally, this manuscript reviews the reported off‐label applications of remimazolam in both the operating room and the intensive care unit (ICU) settings.
